Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
absent, Additionally, aforementioned, aimed, AstraZeneca, auction, began, bought, burdensome, capecitabine, chemotherapy, collateralized, contrast, diversification, domain, earliest, entirety, gastroesophageal, GERD, Helen, highest, hindered, injectable, ixabepilone, Jonathan, Kim, legislation, licensee, multinational, nonfinancial, nonrefundable, OSU, pancreatic, particle, Peiter, plain, prioritized, pursuit, reconciliation, reflux, reorganization, reprioritization, strength, subprime, taxable, tolerability, Trademark, transaction, twelve, vanilla, weaken, Wright, Xeloda
Removed:
Abbott, ACS, adjusted, Advisor, affiliate, agriculture, Alan, Alpha, Alta, altering, American, Amgen, Amsterdam, author, Beta, billion, Biochemistry, biology, biopharmaceutical, Biotech, Biotica, Bombay, Boston, Burr, Cain, Cambridge, caption, Cardiovascular, career, center, Central, chairman, Chiron, collaborating, collectability, colorectal, combinatorial, Conforma, copy, COR, Corporation, CRADA, cumulative, Cyanamid, Department, disclosing, discontinued, discover, Distinguished, diversifying, DNA, dollar, Dr, du, DuPont, Ecole, Egan, electrical, Eli, employed, enable, engineering, enzyme, erythromycin, exceeded, expanded, faculty, feet, foot, formed, Foundation, founded, founder, French, Hamilton, Honor, Hospital, immunosuppressive, India, Indian, inventor, joining, Kappa, Karnofsky, Kuhn, lapse, leased, Lederle, Legion, Leiden, Lilly, London, managing, Master, Medal, medicine, member, Merck, Merite, Millennium, nomination, Omega, Ordre, oxaliplatin, Pennsylvania, pharmacology, pharmacy, Phi, Pieter, Plant, Pont, Portola, professional, Professor, prostate, Pulsar, pure, range, reaction, recipient, renovation, repurchase, Rigel, Rockefeller, School, science, Secretary, served, single, Society, Sofinnova, Sorbonne, square, stereochemistry, stipulated, subsidiary, Superieurie, synthase, Tech, translate, treated, Tularik, unilaterally, unmet, venture, Waterman, Wharton, Yale, York
Filing tables
Filing exhibits
- 10-K Annual report
- 10.1 Form of Indemnification Agreement
- 10.10 2007 Compensation Information for Executive Officers
- 10.43 2008 Compensation Information for Executive Officers
- 10.45 Employment Agreement - Helen S. Kim
- 10.46 Employment Agreement - Jonathan Wright
- 10.47 Form of Executive Employee Restricted Stock Unit Grant Notice
- 10.48 Form of Non-executive Employee Restricted Stock Unit Grant Notice
- 10.49 Severance Benefits and Consulting Agreement - Robert L. De Jager, M.D., F.a.c.p.
- 10.50 Non-employee Director Compensation Arrangements
- 10.51 Employment Agreement - Peter J. Licari, PH.D.
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification Required by Rule 13A-14(A) or Rule 15D-14(A)
- 31.2 Certification Required by Rule 13A-14(A) or Rule 15D-14(A)
- 32.1 Certification by the CEO and CFO As Required by Section 1350 of Title 18
Related press release
KOSN similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-3 Nos. 333-108909, 333-121597, 333-136617 and 333-145485) of Kosan Biosciences Incorporated, |
(2) | Registration Statement (Form S-8 No. 333-63534, 333-96669, 333-115766 and 333-123578) pertaining to the 1996 Stock Option Plan of Kosan Biosciences Incorporated, |
(3) | Registration Statement (Form S-8 No. 333-108502) pertaining to the 1996 Stock Option Plan and 2000 Employee Stock Purchase Plan of Kosan Biosciences Incorporated, |
(4) | Registration Statement (Form S-8 Nos. 333-47758 and 333-132859) pertaining to the 1996 Stock Option Plan, 2000 Employee Stock Purchase Plan and the 2000 Non-Employee Directors’ Stock Option Plan of Kosan Biosciences Incorporated, |
(5) | Registration Statement (Form S-8 No. 333-136067) pertaining to the 2006 Equity Incentive Plan of Kosan Biosciences Incorporated, |
(6) | Registration Statement (Form S-8 No. 333-141437) pertaining to the 2000 Employee Stock Purchase Plan of Kosan Biosciences Incorporated; |
of our report dated March 13, 2008, with respect to the financial statements of Kosan Biosciences Incorporated, our report dated March 13, 2008, with respect to the effectiveness of internal control over financial reporting of Kosan Biosciences Incorporated, included in the Annual Report (Form 10-K) for the year ended December 31, 2007.
/s/ Ernst & Young LLP
San Francisco, California
March 13, 2008